- Home
- SLNO vs HTH Comparison
SLNO vs HTH Comparison
Compare SLNO & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- HTH
- Stock Information
- Founded
- SLNO 1999
- HTH 1998
- Country
- SLNO United States
- HTH United States
- Employees
- SLNO N/A
- HTH N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- HTH Major Banks
- Sector
- SLNO Health Care
- HTH Finance
- Exchange
- SLNO Nasdaq
- HTH Nasdaq
- Market Cap
- SLNO 1.9B
- HTH 1.8B
- IPO Year
- SLNO 2014
- HTH 2004
- Fundamental
- Price
- SLNO $49.17
- HTH $28.95
- Analyst Decision
- SLNO Strong Buy
- HTH Hold
- Analyst Count
- SLNO 6
- HTH 2
- Target Price
- SLNO $74.83
- HTH $34.50
- AVG Volume (30 Days)
- SLNO 567.7K
- HTH 354.3K
- Earning Date
- SLNO 03-05-2025
- HTH 01-30-2025
- Dividend Yield
- SLNO N/A
- HTH 2.33%
- EPS Growth
- SLNO N/A
- HTH N/A
- EPS
- SLNO N/A
- HTH 1.63
- Revenue
- SLNO N/A
- HTH $1,169,826,000.00
- Revenue This Year
- SLNO N/A
- HTH N/A
- Revenue Next Year
- SLNO N/A
- HTH $0.79
- P/E Ratio
- SLNO N/A
- HTH $17.73
- Revenue Growth
- SLNO N/A
- HTH N/A
- 52 Week Low
- SLNO $36.61
- HTH $26.67
- 52 Week High
- SLNO $60.92
- HTH $35.32
- Technical
- Relative Strength Index (RSI)
- SLNO 56.57
- HTH 48.12
- Support Level
- SLNO $45.44
- HTH $26.67
- Resistance Level
- SLNO $49.03
- HTH $29.11
- Average True Range (ATR)
- SLNO 2.36
- HTH 0.60
- MACD
- SLNO 0.66
- HTH 0.21
- Stochastic Oscillator
- SLNO 98.40
- HTH 87.69
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. Its primary line of business is to provide business and consumer banking services from offices throughout Texas through the PlainsCapital Bank. The company also provides other financial products and services through its broker-dealer and mortgage origination segments. The company generates a majority of its revenue through its banking operations.